China · Delayed Price · Currency is CNY Bio-Thera Solutions Statistics
Total Valuation
SHA:688177 has a market cap or net worth of CNY 6.72 billion. The enterprise value is 7.23 billion.
| Market Cap | 6.72B |
| Enterprise Value | 7.23B |
Important Dates
The last earnings date was Wednesday, August 26, 2026.
| Earnings Date | Aug 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHA:688177 has 414.08 million shares outstanding. The number of shares has decreased by -0.51% in one year.
| Current Share Class | 414.08M |
| Shares Outstanding | 414.08M |
| Shares Change (YoY) | -0.51% |
| Shares Change (QoQ) | +1.32% |
| Owned by Insiders (%) | 17.93% |
| Owned by Institutions (%) | 6.16% |
| Float | 107.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 6.65 |
| PB Ratio | 54.26 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 105.52 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.65, with a Debt / Equity ratio of 7.25.
| Current Ratio | 0.65 |
| Quick Ratio | 0.34 |
| Debt / Equity | 7.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | -5.45 |
| Interest Coverage | -53.24 |
Financial Efficiency
Return on equity (ROE) is -129.83% and return on invested capital (ROIC) is -70.68%.
| Return on Equity (ROE) | -129.83% |
| Return on Assets (ROA) | -12.68% |
| Return on Invested Capital (ROIC) | -70.68% |
| Return on Capital Employed (ROCE) | -59.04% |
| Weighted Average Cost of Capital (WACC) | 5.69% |
| Revenue Per Employee | 709,592 |
| Profits Per Employee | -321,863 |
| Employee Count | 1,426 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 0.63 |
Taxes
In the past 12 months, SHA:688177 has paid 318,456 in taxes.
| Income Tax | 318,456 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -45.60% in the last 52 weeks. The beta is 0.38, so SHA:688177's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | -45.60% |
| 50-Day Moving Average | 18.45 |
| 200-Day Moving Average | 21.10 |
| Relative Strength Index (RSI) | 31.30 |
| Average Volume (20 Days) | 3,902,964 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:688177 had revenue of CNY 1.01 billion and -458.98 million in losses. Loss per share was -1.11.
| Revenue | 1.01B |
| Gross Profit | 811.81M |
| Operating Income | -489.14M |
| Pretax Income | -458.66M |
| Net Income | -458.98M |
| EBITDA | -368.89M |
| EBIT | -489.14M |
| Loss Per Share | -1.11 |
Balance Sheet
The company has 395.52 million in cash and 898.00 million in debt, with a net cash position of -502.48 million or -1.21 per share.
| Cash & Cash Equivalents | 395.52M |
| Total Debt | 898.00M |
| Net Cash | -502.48M |
| Net Cash Per Share | -1.21 |
| Equity (Book Value) | 123.94M |
| Book Value Per Share | 0.30 |
| Working Capital | -610.96M |
Cash Flow
In the last 12 months, operating cash flow was 63.73 million and capital expenditures -228.56 million, giving a free cash flow of -164.84 million.
| Operating Cash Flow | 63.73M |
| Capital Expenditures | -228.56M |
| Depreciation & Amortization | 120.25M |
| Net Borrowing | 257.01M |
| Free Cash Flow | -164.84M |
| FCF Per Share | -0.40 |
Margins
Gross margin is 80.23%, with operating and profit margins of -48.34% and -45.36%.
| Gross Margin | 80.23% |
| Operating Margin | -48.34% |
| Pretax Margin | -45.33% |
| Profit Margin | -45.36% |
| EBITDA Margin | -36.46% |
| EBIT Margin | -48.34% |
| FCF Margin | n/a |
Dividends & Yields
SHA:688177 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.51% |
| Shareholder Yield | 0.51% |
| Earnings Yield | -6.83% |
| FCF Yield | -2.45% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |